Skip to contentSmith Robin L — PHASE III MEDICAL INC/DE insider: 192 transactions · InsiderLensSmith Robin L
- Director at PHASE III MEDICAL INC/DE · on record since Jun 6, 2006
- Director at Matinas BioPharma Holdings, Inc. · on record since Feb 13, 2025
- Director at Viridian Therapeutics, Inc.\DE · on record since Jun 17, 2014
- Executive Chair of the Board at PHASE III MEDICAL INC/DE · on record since Jun 4, 2015
- Director at STRATIVATION, INC. · on record since Aug 24, 2015
- Director at ROCKWELL MEDICAL TECHNOLOGIES INC · on record since Jun 27, 2016
- Director at MAN-GLENWOOD LEXINGTON ASSOCIATES PORTFOLIO LLC · on record since Jun 14, 2017
- Director at Mynd.ai, Inc. · on record since Aug 23, 2017
- Director at FRESH MEDICAL LABORATORIES, INC. · on record since May 14, 2018
- Director at NEXMED INC · on record since Jan 28, 2019
- Director at QUIKBYTE SOFTWARE INC · on record since Dec 18, 2019
- Director at SERVICESOURCE INTERNATIONAL, INC. · on record since Mar 6, 2020
- Director at Celularity Inc · on record since Jul 20, 2021
- Director at Western Acquisition Ventures Corp. · on record since Jan 11, 2022
Insider trading activity of Smith Robin L
- Transactions on record
- 192
- since Jun 6, 2006
- Open-market buys
- 11
- $54.7M
- Open-market sells
- 0
- Companies traded
- 12
- last filing May 2, 2025
Figures computed from official regulatory filings — methodology.
Companies where Smith Robin L has traded
- Matinas BioPharma Holdings, Inc.1 tx · May 2, 2025
- Celularity Inc9 tx · Jun 16, 2023
- QUIKBYTE SOFTWARE INC8 tx · $876K · Sep 3, 2021
- SERVICESOURCE INTERNATIONAL, INC.3 tx · $85K · May 21, 2020
- NEXMED INC3 tx · Jan 7, 2020
- ROCKWELL MEDICAL TECHNOLOGIES INC5 tx · Jun 10, 2019
- Mynd.ai, Inc.18 tx · $84.5K · May 10, 2019
- FRESH MEDICAL LABORATORIES, INC.1 tx · May 14, 2018
- MAN-GLENWOOD LEXINGTON ASSOCIATES PORTFOLIO LLC5 tx · Aug 30, 2017
Track record of Smith Robin L
Statistical track record
Free- Open-market buys
- 17
- Last buy
- May 20, 2020
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Smith Robin L
Co-insiders of Smith Robin L
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
11 tx · $9.2K · Feb 7, 2017
Dickey Robert IVPHASE III MEDICAL INC/DE +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| May 2, 2025 | AwardD | 11,600 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | AwardD | 277,778 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | Award | 199,921 | 0.00 USD | $0 | SEC |
| Aug 18, 2022 | AwardD | 800,000 | 0.00 USD | $0 | SEC |
| Aug 18, 2022 | AwardD | 250,000 | 0.00 USD | $0 | SEC |
| Jul 15, 2022 | AwardD | 54,152 | 0.00 USD | $0 | SEC |
| Jul 15, 2022 | Award | 36,145 | 0.00 USD | $0 | SEC |
| Sep 13, 2021 | AwardD | 56,053 | 0.00 USD | $0 | SEC |
| Sep 3, 2021 | Exercise | 100,000 | 4.89 USD | $489K | SEC |
| Sep 3, 2021 | ExerciseD | -100,000 | 0.00 USD | $0 | SEC |
| Sep 3, 2021 | ExerciseD | -75,000 | 0.00 USD | $0 | SEC |
| Sep 3, 2021 | Exercise | 75,000 | 3.95 USD | $296.3K | SEC |
| Aug 30, 2021 | AwardD | 250,000 | 0.00 USD | $0 | SEC |
| Jul 20, 2021 | AwardD | 384,297 | 0.00 USD | $0 | SEC |
| Jul 20, 2021 | AwardD | 269,007 | 0.00 USD | $0 | SEC |
| Jun 15, 2020 | AwardD | 100,000 | 0.00 USD | $0 | SEC |
| May 21, 2020 | Buy | 50,000 | 1.70 USD | $85K | SEC |
| May 14, 2020 | Award | 100,000 | 0.00 USD | $0 | SEC |
| Mar 6, 2020 | Award | 17,975 | 0.00 USD | $0 | SEC |
| Mar 5, 2020 | Buy | 40,000 | 2.27 USD | $90.8K | SEC |
| Jan 7, 2020 | AwardD | 16,000 | 0.00 USD | $0 | SEC |
| Dec 18, 2019 | AwardD | 75,000 | 0.00 USD | $0 | SEC |
| Jun 10, 2019 | Award | 21,566 | 0.00 USD | $0 | SEC |
| Jun 10, 2019 | AwardD | 22,461 | 0.00 USD | $0 | SEC |
| May 10, 2019 | AwardD | 100,000 | — | — | SEC |